Xalatan (latanoprost) is now approved for the INITIAL treatment of glaucoma

Xalatan (latanoprost) is now approved for the INITIAL treatment of glaucoma.

For years, topical beta-blockers (timolol, etc) were preferred. But respiratory problems and bradycardia are a concern.

Xalatan works at least as well as timolol...and has fewer systemic effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote